EcoDrugPlus

Ensembl ID : ENSCHYG00000026079
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSCHYG00000025465
Gene Symbol: -
Cross references: -
269 Possible Orthologues:

Ensembl ID : ENSCHYG00000021370
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSCHYG00000021051
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSCHYG00000021046
Gene Symbol: -
Cross references: -
285 Possible Orthologues:

Ensembl ID : ENSCHYG00000020855
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSCHYG00000018421
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSCHYG00000014468
Gene Symbol: -
Cross references: -
234 Possible Orthologues:

Ensembl ID : ENSCHYG00000013103
Gene Symbol: -
Cross references: -
305 Possible Orthologues:

Ensembl ID : ENSCHYG00000013306
Gene Symbol: -
Cross references: -
85 Possible Orthologues:

Ensembl ID : ENSCHYG00000010021
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSCHYG00000025132
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).